TY - JOUR
T1 - Update on the Methods of the U.S. Preventive Services Task Force
T2 - Linking Intermediate Outcomes and Health Outcomes in Prevention
AU - Wolff, Tracy A.
AU - Krist, Alex H.
AU - LeFevre, Michael
AU - Jonas, Daniel E.
AU - Harris, Russell P.
AU - Siu, Albert
AU - Owens, Douglas K.
AU - Gillman, Matthew W.
AU - Ebell, Mark H.
AU - Herzstein, Jessica
AU - Chou, Roger
AU - Whitlock, Evelyn
AU - Bibbins-Domingo, Kirsten
N1 - Funding Information:
Publication of this article was supported by the Agency for Healthcare Research and Quality (AHRQ) through contract #HHSA290201600006C. The U.S. Preventive Services Task Force (USPSTF) is an independent, voluntary body. The U.S. Congress mandates that AHRQ support the operations of the USPSTF. The findings and conclusions in this document are those of the authors, who are responsible for its content, and do not necessarily represent the views of AHRQ. No statement in this report should be construed as an official position of AHRQ, the U.S. Department of Health and Human Services, or the National Institutes of Health. No financial disclosures were reported by the authors of this paper.
Funding Information:
Dan Jonas and Russell Harris were supported in their work by the Agency for Healthcare Research and Quality, U.S. DHHS Contract No.: HHSA290201000005I, Task Order #3. Roger Chou and Dan Jonas have received funding from the AHRQ to conduct systematic reviews for the USPSTF.
Publisher Copyright:
© 2018
PY - 2018/1
Y1 - 2018/1
N2 - The U.S. Preventive Services Task Force (USPSTF) is an independent body of experts who make evidence-based recommendations about clinical preventive services using a transparent and objective process. Developing recommendations on a clinical preventive service requires evidence of its effect on health outcomes. Health outcomes are symptoms, functional levels, and conditions that affect a patient's quantity or quality of life and are measured by assessments of physical or psychologic well-being. Intermediate outcomes are pathologic, physiologic, psychologic, social, or behavioral measures related to a preventive service. Given the frequent lack of evidence on health outcomes, the USPSTF uses evidence on intermediate outcomes when appropriate. The ultimate goal is to determine precisely a consistent relationship between the direction and magnitude of change in an intermediate outcome with a predictable resultant direction and magnitude of change in the health outcomes. The USPSTF reviewed its historical use of intermediate outcomes, reviewed methods of other evidence-based guideline-making bodies, consulted with other experts, and reviewed scientific literature. Most important were the established criteria for causation, tenets of evidence-based medicine, and consistency with its current standards. Studies that follow participants over time following early treatment, stratify patients according to treatment response, and adjust for important confounders can provide useful information about the association between intermediate and health outcomes. However, such studies remain susceptible to residual confounding. The USPSTF will exercise great caution when making a recommendation that depends on the evidence linking intermediate and health outcomes because of inherent evidence limitations.
AB - The U.S. Preventive Services Task Force (USPSTF) is an independent body of experts who make evidence-based recommendations about clinical preventive services using a transparent and objective process. Developing recommendations on a clinical preventive service requires evidence of its effect on health outcomes. Health outcomes are symptoms, functional levels, and conditions that affect a patient's quantity or quality of life and are measured by assessments of physical or psychologic well-being. Intermediate outcomes are pathologic, physiologic, psychologic, social, or behavioral measures related to a preventive service. Given the frequent lack of evidence on health outcomes, the USPSTF uses evidence on intermediate outcomes when appropriate. The ultimate goal is to determine precisely a consistent relationship between the direction and magnitude of change in an intermediate outcome with a predictable resultant direction and magnitude of change in the health outcomes. The USPSTF reviewed its historical use of intermediate outcomes, reviewed methods of other evidence-based guideline-making bodies, consulted with other experts, and reviewed scientific literature. Most important were the established criteria for causation, tenets of evidence-based medicine, and consistency with its current standards. Studies that follow participants over time following early treatment, stratify patients according to treatment response, and adjust for important confounders can provide useful information about the association between intermediate and health outcomes. However, such studies remain susceptible to residual confounding. The USPSTF will exercise great caution when making a recommendation that depends on the evidence linking intermediate and health outcomes because of inherent evidence limitations.
UR - http://www.scopus.com/inward/record.url?scp=85038090353&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85038090353&partnerID=8YFLogxK
U2 - 10.1016/j.amepre.2017.08.032
DO - 10.1016/j.amepre.2017.08.032
M3 - Article
C2 - 29254525
AN - SCOPUS:85038090353
SN - 0749-3797
VL - 54
SP - S4-S10
JO - American journal of preventive medicine
JF - American journal of preventive medicine
IS - 1
ER -